HDV - iShares Core High Dividend ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
94.87
-0.43 (-0.45%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close95.30
Open95.20
Bid94.53 x 1100
Ask95.28 x 3100
Day's Range94.82 - 95.23
52 Week Range79.39 - 95.38
Volume294,668
Avg. Volume576,761
Net Assets7.01B
NAV95.31
PE Ratio (TTM)N/A
Yield3.34%
YTD Return14.03%
Beta (3Y Monthly)0.72
Expense Ratio (net)0.08%
Inception Date2011-03-29
Trade prices are not sourced from all markets
  • Top-Ranked Dividend ETFs Crushing the Market
    Zackslast month

    Top-Ranked Dividend ETFs Crushing the Market

    We have highlighted five dividend ETFs that are clearly outpacing the broad market indices by wide margins and have a Zacks ETF Rank 1 or 2, suggesting further outperformance in the months ahead.

  • 7 Inexpensive, High-Dividend ETFs to Buy
    InvestorPlacelast month

    7 Inexpensive, High-Dividend ETFs to Buy

    Editor's note: This story was previously published in September 2018. It has since been updated and republished.The universe of exchange-traded funds (ETFs) is awash in low-fee products, and the space is growing as issuers reduce their fees to lure investors.Income-seeking investors do not have to pay up to access high-dividend ETFs. In fact, numerous high-dividend ETFs can be inexpensive, which is an important point for income investors looking to keep more of those dividends and a higher share of their invested capital. High-dividend ETFs are often embraced by long-term investors and over the long-term, lower fees can mean better outcomes for investors.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOver the past several years, data confirm that when it comes to adding new assets, the best ETFs are usually those with annual fees of 0.20% or less. Plenty of high-dividend ETFs fit into that category, making it a cost-effective method for thrifty investors to access broad baskets of dividend stocks. * 15 Stocks Sitting on Huge Piles of Cash Here are some high-dividend ETFs, with very low fees, for income-minded investors to consider. High-Dividend ETFs to Buy: iShares Core High Dividend ETF (HDV)Expense Ratio: 0.08%, or $8 annually per $10,000 investmentMany high dividend ETFs weight components by yield, a strategy that has some drawbacks. Those disadvantages include vulnerability to rising interest rates and the potential for exposure to financially challenged companies that may have trouble maintaining and growing dividends.The iShares Core High Dividend ETF (NYSEARCA:HDV) has a 12-month dividend yield of 3.03%, which is well above the S&P 500 and 10-year Treasuries. However, this high-dividend ETF follows the Morningstar Dividend Yield Focus Index, which screens companies for financial health, giving the fund a quality look.With an annual fee of just 0.08%, HDV is one of the cheaper high dividend ETFs on the market today. That low fee coupled with its sector allocations make HDV ideal for conservative investors. The healthcare, consumer staples, telecom and utilities sectors, four of HDV's top five sector weights, can all be considered defensive groups. High-Dividend ETFs to Buy: SPDR Portfolio S&P 500 High Dividend ETF (SPYD)Expense Ratio: 0.08%The SPDR Portfolio S&P 500 High Dividend ETF (NYSEARCA:SPYD) is one of the least expensive dividend ETFs on the market, high dividend or otherwise. The ETF tracks the S&P 500 High Dividend Index, the high-dividend offshoot of the traditional S&P 500.SPYD's yield requirement gives this high-dividend ETF a focused roster of just 80 stocks, but the 12-month dividend yield of 4.65% makes this high-dividend ETF appealing for income investors relative to standard broad market funds. * 15 Stocks Sitting on Huge Piles of Cash SPYD relies heavily on high income sectors that have shown historical vulnerability to rising interest rates -- a trait to keep in mind in the current market environment. The real estate and utilities sectors combine for almost 35% of this high dividend ETF's weight. High-Dividend ETFs to Buy: Invesco Dow Jones Industrial Average Dividend ETF (DJD)Expense Ratio: 0.3%The Invesco Dow Jones Industrial Average Dividend ETF (NYSEARCA:DJD) is a yield-weighted approach to the venerable Dow Jones Industrial Average. What this high-dividend ETF does is weigh the 30 Dow stocks by their trailing 12-month dividend, not price, as the traditional Dow does.DJD's yield focus makes Verizon Communications (NYSE:VZ) the high dividend ETF's largest holding. DJD's largest sector weight is technology, and the fund devotes just 12.36 to industrials.While DJD appears to be a high-dividend ETF, the fund offers significant dividend growth potential because many of the Dow's 30 member firms have payout-increase streaks that can be measured in decades. High-Dividend ETFs to Buy: Invesco S&P 500 Quality ETF (SPHQ)Expense Ratio: 0.28%With a distribution rate of just 1.8%, the Invesco S&P 500 Quality ETF (NYSEARCA:SPHQ) does not scream "high dividend ETF." SPHQ's underlying index, the S&P 500 Quality Index, does not even emphasize dividends.Rather, that benchmark focuses on firm's "that have the highest quality score, which is calculated based on three fundamental measures, return on equity, accruals ratio and financial leverage ratio," according to Invesco. While SPHQ is not explicitly a high -dividend fund, reliable, growing dividends are often a hallmark of companies meeting the standards of the quality factor. * 15 Stocks Sitting on Huge Piles of Cash With a combined weight of over 40% to the technology and consumer services sectors, SPHQ has the feel of a growth ETF, but that means this fund also pairs well with more traditional high-dividend ETFs, such as some of the funds highlighted above. High-Dividend ETFs to Buy: Vanguard High Dividend Yield ETF (VYM)Expense Ratio: 0.06%Home to $22.72 billion in total net assets, the Vanguard High Dividend Yield ETF (NYSEARCA:VYM) is one of the largest dividend ETFs of any variety. It is not unreasonable to believe that VYM's name frames the fund as a high-dividend ETF, but a yield of 3.44% is not alarmingly high.More importantly, VYM is not overly dependent on rate-sensitive sectors. This high-dividend ETF features no real estate exposure and the bond-esque telecom and utilities sectors combine for just 12.80% of VYM's weight.A quarter of the fund's holdings hail from the industrial and healthcare sectors. Financials, a sector that has been a major driver of S&P 500 dividend growth over the past year, is this high dividend ETF's largest sector exposure at 15.3%. High-Dividend ETFs to Buy: JPMorgan U.S. Dividend ETF (JDIV)Expense Ratio: 0.12%The JPMorgan U.S. Dividend ETF (NYSEARCA:JDIV) is one of the youngest funds on this list, having debuted in late 2017, but it fits the bill as a cost-effective, high-dividend ETF. JDIV "utilizes a rules-based approach that adjusts sector weights based on volatility and yield and selects the highest yielding stocks," according to the issuer.With a 12-month yield of 4.07%, JDIV has high-dividend ETF credentials. JDIV's annual fee of 0.12% is quite low. * 15 Stocks Sitting on Huge Piles of Cash High-Dividend ETFs to Buy: Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF)Expense Ratio: 0.33%The Xtrackers MSCI EAFE High Dividend Yield Equity ETF (NYSEARCA:HDEF) targets the MSCI EAFE High Dividend Yield Index, a benchmark that is a high-dividend derivative of the widely followed MSCI EAFE Index.While HDEF is a credible name among international high dividend ETFs, the laggard status of European stocks has hindered HDEF in recent months. On the more positive side of the ledger is ex-U.S. dividend growth and valuation opportunities across developed markets, two traits that speak to long-term opportunity with HDEF.As of this writing, Todd Shriber did not own any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 of the Best Stocks to Buy Under $10 * 7 Retail Stocks Winning in 2019 and Beyond * The 10 Best Stocks to Buy for the Bull Market's Anniversary Compare Brokers The post 7 Inexpensive, High-Dividend ETFs to Buy appeared first on InvestorPlace.

  • Dividend ETF (HDV) Hits New 52-Week High
    Zackslast month

    Dividend ETF (HDV) Hits New 52-Week High

    This dividend ETF has hit a new 52-week high. Are more gains in store?

  • ETF Trends2 months ago

    How CLS Investments Is Getting Strategic With Dividend ETFs

    In 2018, U.S. dividend growth remained solid, although some dividend exchange traded funds (ETFs) were challenged by the Federal Reserve's four interest rate hikes. Expectations are in place that the Fed will slow its pace of rate hikes this year or possibly not raise rates at all. Joe Smith, deputy chief investment officer (CIO), at CLS Investments ($9.2 billion AUM), recently discussed his firm's approach to dividend strategies with ETF Trends.

  • Morningstar2 months ago

    Vanguard's Latest Fee Cuts in 4 Charts

    This article originally appeared in Morningstar Direct Cloud and Morningstar Office Cloud. The pace of fee cuts on passively managed funds may have slowed in some corners of the fund universe, but not at Vanguard.

  • Emerging Market and Dividend: 2 ETFs to Watch on Outsized Volume
    Zacks3 months ago

    Emerging Market and Dividend: 2 ETFs to Watch on Outsized Volume

    PIE and HDV saw massive trading volumes in yesterday session.

  • Zacks3 months ago

    Banks Keep Stocks Moving Higher

    Banks Keep Stocks Moving Higher

  • A Dividend ETF Investing Guide
    Zacks4 months ago

    A Dividend ETF Investing Guide

    Dividend paying securities are the major source of consistent income for investors to create wealth when returns from the equity market are at risk.

  • Merck’s Stock Price Has Increased ~34% in 2018
    Market Realist5 months ago

    Merck’s Stock Price Has Increased ~34% in 2018

    On November 16, Merck’s (MRK) stock price closed at $76.06, which represents ~1.63% growth from its close of $74.84 on November 15. Merck’s stock price grew from $56.79 when the market opened on January 2 to $76.06 when the market closed on November 16, which representing ~34% year-to-date growth. On November 16, Merck hit its 52-week high of $76.25.

  • Top ETFs: As Dividends Compare More Favorably, IShares ETF Emerges As A Leader
    Investor's Business Daily5 months ago

    Top ETFs: As Dividends Compare More Favorably, IShares ETF Emerges As A Leader

    When the stock market gets rough, investors often flee to dividend stocks, which explains why iShares Core High Dividend is now in IBD's ETF Leaders screen of top ETFs.

  • How Wall Street Analysts View Merck
    Market Realist6 months ago

    How Wall Street Analysts View Merck

    On October 25, Merck & Co. (MRK) announced a dividend of $0.55 per share for its outstanding common stock in the fourth quarter of 2018. That’s a ~15% increase from its dividend of $0.48 per share in the fourth quarter of 2017.

  • 37% of Analysts Rate 3M as a ‘Buy’ after Its Q3 2018 Earnings
    Market Realist6 months ago

    37% of Analysts Rate 3M as a ‘Buy’ after Its Q3 2018 Earnings

    The consensus target price for 3M stock has fallen since its earnings release. The current analyst consensus indicates a target price of $205.94, compared to $213.60 before its third-quarter earnings release.

  • How Is Johnson & Johnson’s Vision Care Business Positioned?
    Market Realist6 months ago

    How Is Johnson & Johnson’s Vision Care Business Positioned?

    Johnson & Johnson’s (JNJ) Vision Care segment generated revenues of $1.13 billion in the third quarter compared to $1.09 billion in the third quarter of 2017, reflecting ~3.8% YoY (year-over-year) growth.

  • What’s Pfizer’s Current Valuation?
    Market Realist6 months ago

    What’s Pfizer’s Current Valuation?

    In this part, we’ll compare Pfizer’s (PFE) valuation with its peers including Merck (MRK), Johnson & Johnson (JNJ), Eli Lilly (LLY), and Bristol-Myers Squibb (BMY).

  • A Guide to Dividend ETF Investing
    Zacks6 months ago

    A Guide to Dividend ETF Investing

    We have highlighted 10 most popular dividend ETFs for investors seeking yields and returns in a rocky market.

  • What’s Expected for Merck’s Q3 2018 Earnings
    Market Realist6 months ago

    What’s Expected for Merck’s Q3 2018 Earnings

    Analysts expect Merck (MRK) to report GAAP net income of $2.23 billion and GAAP EPS of $0.83 in the third quarter of 2018. In Q2 2018, the company’s GAAP net income fell YoY (year-over-year) from $1.9 billion to $1.7 billion, and its GAAP EPS fell YoY from $0.71 to $0.63. Merck’s non-GAAP net income grew ~3% YoY in Q2 2018, to $2.9 billion from $2.8 billion, and its non-GAAP EPS grew ~5% YoY from $1.01 to $1.06.

  • Pfizer’s Dividend Growth Trend and Analysts’ Recommendations
    Market Realist7 months ago

    Pfizer’s Dividend Growth Trend and Analysts’ Recommendations

    In June, Pfizer (PFE) announced a dividend of $0.34 for the third quarter on the company’s common stock. Pfizer paid a cash dividend of $0.34 on September 4 to its shareholders of record on August 3. Pfizer delivered a dividend yield of 3.11% in the third quarter.

  • ETF Trends9 months ago

    Dividend ETFs: Capitalizing on a Trump Bump?

    President Donald Trump enacted a tax reform plan that allowed companies to repatriate billions of dollars in overseas revenue back home, driving increased demand for dividend stock ETF strategies that ...

  • Merck’s Post-1Q18 Valuation
    Market Realist11 months ago

    Merck’s Post-1Q18 Valuation

    In 1Q18, Merck’s revenue grew 6% YoY (year-over-year) to $10.0 billion from $9.4 billion, and its EPS (earning per share) rose to $1.05 from $0.88. In this part, we’ll look at how Merck’s valuation multiples compare.

  • What’s Johnson & Johnson’s Valuation after 1Q18 Earnings?
    Market Realistlast year

    What’s Johnson & Johnson’s Valuation after 1Q18 Earnings?

    As discussed earlier, Johnson & Johnson (JNJ) reported revenue growth of 12.6% in its 1Q18 revenues to $20.0 billion.